Drug or chemical induced diabetes mellitus with skin complications
ICD-10 E09.62 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with skin complications.
Drug or chemical induced diabetes mellitus is a condition where diabetes develops as a result of exposure to certain medications or chemicals. This can occur due to various pharmacological agents, including glucocorticoids, antipsychotics, and certain chemotherapy drugs. The skin complications associated with this type of diabetes can include infections, diabetic dermopathy, and necrobiosis lipoidica. Patients may present with elevated blood glucose levels and skin manifestations that require careful management. The condition is often reversible upon discontinuation of the offending agent, but it can lead to chronic complications if not managed properly. Monitoring HbA1c levels is crucial for assessing long-term glycemic control, and insulin management may be necessary depending on the severity of the diabetes. The presence of skin complications necessitates a multidisciplinary approach to treatment, including dermatological care.
Detailed history of medication use, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting a new medication.
Endocrinologists must ensure clear documentation of the relationship between the drug and diabetes onset.
Clinical notes on skin manifestations, treatment plans, and follow-up care.
Patients with skin infections or lesions related to diabetes.
Dermatologists should document the diabetes management plan to ensure comprehensive care.
Used for follow-up visits for diabetes management and skin complications.
Document the patient's diabetes status, treatment plan, and any skin issues.
Endocrinologists should ensure comprehensive documentation of diabetes management.
Common drugs that can induce diabetes include glucocorticoids, certain antipsychotics, thiazide diuretics, and some antiretroviral medications.
